Page last updated: 2024-08-01 07:06:05

1,2-diamino-4-nitrobenzene

Description

1,2-diamino-4-nitrobenzene: reagent for determination of selenium in milk with gas chromatograph [MeSH]

4-nitro-1,2-phenylenediamine : The primary amino compound that is 1,2-phenylenediamine (o-phenylenediamine) substituted at the 4- (para-) position by a nitro group. [CHeBI]

Cross-References

ID SourceID
PubMed CID5111791
CHEMBL ID433721
SCHEMBL ID78293
CHEBI ID67116
MeSH IDM0059207

Synonyms (91)

Synonym
AC-2759
(2-amino-5-nitro-phenyl)-amine
o-phenylenediamine, 4-nitro-
4-nitro-1,2-phenylenediamine
4-nopd
4-nitro-o-phenylenediamine
99-56-9
nsc5378
nci-c03941
2-amino-4-nitroaniline
c.i. 76020
nsc-5378
4-nitro-1,2-diaminobenzene
4-nitro-1,2-benzenediamine
p-nitro-o-phenylenediamine
wln: zr bz dnw
4-n-o-pda
3,4-diaminonitrobenzene
4-nop
4-no
1,2-diamino-4-nitrobenzene
4-nitrobenzene-1,2-diamine
nsc 5378
ci 76020
1,2-benzenediamine, 4-nitro-
4-nitrophenylenediamine
einecs 202-766-3
4-nitro-o-phenylene-diamine
hsdb 2895
brn 0608106
ai3-52605
4-nitro-1,2-fenylendiamin [czech]
4-nitro-para-phenylenediamine
ccris 451
4ndb
NCGC00091593-01
STK317795
inchi=1/c6h7n3o2/c7-5-2-1-4(9(10)11)3-6(5)8/h1-3h,7-8h
4-nitro-o-phenylenediamine, 98%
NCGC00091593-02
D0103
chebi:67116 ,
CHEMBL433721
AKOS000119818
BBL016368
NCGC00091593-03
C19384
tox21_302811
NCGC00256320-01
cas-99-56-9
dtxcid30958
dtxsid9020958 ,
NCGC00259862-01
tox21_202313
4-nitrobenzene-1,2-diamine;1,2-diamino-4-nitrobenzene
4-13-00-00075 (beilstein handbook reference)
4-nitro-1,2-fenylendiamin
unii-5a9ax7y0tt
nitro-o-phenylenediamine
5a9ax7y0tt ,
FT-0614201
p-nitro-o-phenylendiamine
SCHEMBL78293
4-nitrophenylene diamine
3,4-diamino-nitrobenzene
4-nitro 1,2-phenylenediamine
4-nitro-ortho-phenylenediamine
4-nitro-o-phenylene diamine
4-nitro-benzene-1,2-diamine
2-amino-5-nitroaniline
4-nitro 1,2-phenylene diamine
4-nitro-o-phenylenediamine [who-dd]
4-nitro-o-phenylenediamine [mi]
o-phenylenediamine, 4-nitro- [hsdb]
1,2-diamino-4-nitrobenzene [iarc]
4-nitro-o-phenylenediamine [inci]
W-100032
mfcd00007724
CS-W007627
F0001-2335
GS-3013
1,2-benzenediamine,4-nitro-
58833-52-6
Q5649571
CCG-325544
EN300-19619
D77683
4-nitrobenzene-1
4-nitro-1,2-diamino-benzene
2-amino-4-nitrophenylamine
Z104474480

Drug Classes (2)

ClassDescription
primary amino compoundA compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.

Protein Targets (34)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency84.4996AID1224835
acetylcholinesteraseHomo sapiens (human)Potency67.9626AID1347395; AID1347397; AID1347398; AID1347399
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency24.5322AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency19.0261AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency21.8644AID1346924
SMAD family member 3Homo sapiens (human)Potency21.8644AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency5.5785AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency39.8133AID1259243; AID588515; AID588516; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency68.5199AID1346978
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency28.6790AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency25.8809AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency26.1529AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency16.2110AID588532; AID588533
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.6084AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.0798AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency47.9178AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency0.0025AID588527
pregnane X nuclear receptorHomo sapiens (human)Potency22.8146AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency26.1339AID1259244; AID1259383; AID743069; AID743075; AID743077; AID743078; AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency13.8006AID743094
caspase-3Homo sapiens (human)Potency68.5199AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency62.0041AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.5199AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency43.2137AID1224843; AID1224895; AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency3.1786AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency13.7955AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency71.8999AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency46.3490AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency10.9382AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency12.5475AID651741; AID720636; AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency24.3118AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency31.1313AID651631; AID651743
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency24.3118AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency42.1632AID651802

Bioassays (15)

Assay IDTitleYearJournalArticle
AID1243765Mutagenicity in Salmonella typhimurium TA98 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to untreated control2015European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
ISSN: 0022-2623
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1243789Mutagenicity in Salmonella typhimurium TA97a assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to untreated control2015European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID1761351Genotoxicity in Salmonella typhimurium TA1537 assessed as number of revertant by Ames spot test relative to solvent control2021European journal of medicinal chemistry, Feb-05, Volume: 211ISSN: 1768-3254
AID1243831Mutagenicity in Salmonella typhimurium TA100 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in presence of liver S9 fractions by Ames test relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID1265553Mutagenicity in Salmonella typhimurium TA98 assessed as number of revertants at 10 ug/plate by Ames test (Rvb = 23 +/- 3 No_unit)2016European journal of medicinal chemistry, Jan-01, Volume: 107ISSN: 1768-3254Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols.
AID1720784Genotoxicity in Salmonella typhimurium TA98 assessed as mutagenic index at 2.5 ug by AMES test2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
ISSN: 1464-3405
AID1570687Mutagenicity in Salmonella typhimurium TA100 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
ISSN: 1464-3405
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
AID1720774Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertant at 2.5 ug by AMES test (Rvb = 8 to 8.3 No_unit)2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
ISSN: 1464-3405
AID732979Mutagenicity in Salmonella typhimurium TA98 at 20 ug/plate in absence of S9 fraction2013European journal of medicinal chemistry, Jan, Volume: 59ISSN: 1768-3254Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates.
AID1243813Mutagenicity in Salmonella typhimurium TA98 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID1761352Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertant by Ames spot test relative to solvent control2021European journal of medicinal chemistry, Feb-05, Volume: 211ISSN: 1768-3254
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
ISSN: 0022-2623
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1570689Mutagenicity in Salmonella typhimurium TA102 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
ISSN: 1464-3405
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
AID1570688Mutagenicity in Salmonella typhimurium TA98 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
ISSN: 1464-3405
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (9.62)18.7374
1990's13 (25.00)18.2507
2000's15 (28.85)29.6817
2010's15 (28.85)24.3611
2020's4 (7.69)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (98.18%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
agmatineguanidines;
primary amino compound
Escherichia coli metabolite;
mouse metabolite
00low000000
aminoethylphosphonic acidphosphonic acids;
primary amino compound;
zwitterion
human metabolite;
metabolite;
mouse metabolite
00low000000
4-amino-1,2-oxazolidin-3-onehydroxamic acid ester;
oxazolidines;
primary amino compound;
serine derivative
00low000000
phosphorylethanolaminephosphoethanolamine;
primary amino compound
algal metabolite;
human metabolite;
mouse metabolite
00low000000
n-(3-(aminomethyl)benzyl)acetamidinearalkylamine;
carboxamidine;
primary amino compound
angiogenesis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector
00low000000
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridineimidazopyridine;
primary amino compound
carcinogenic agent;
mutagen
00low000000
2-aminoethoxydiphenyl borateorganoboron compound;
primary amino compound
calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener
00low000000
3-methoxytyraminemonomethoxybenzene;
phenols;
phenylethylamine;
primary amino compound
biomarker;
human blood serum metabolite;
human urinary metabolite
00low000000
3-hydroxy-4-methoxyphenethylaminemonomethoxybenzene;
phenols;
phenylethylamine;
primary amino compound
human metabolite;
rat metabolite
00low000000
5-(nonyloxy)tryptaminearomatic ether;
primary amino compound;
tryptamines
serotonergic agonist00low000000
5-methoxytryptaminearomatic ether;
primary amino compound;
tryptamines
5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist
00low000000
alendronate1,1-bis(phosphonic acid);
primary amino compound
bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
00low000000
amfenacamino acid;
benzophenones;
oxo monocarboxylic acid;
primary amino compound;
substituted aniline
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
ampyroneprimary amino compound;
pyrazolone
antipyretic;
antirheumatic drug;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
marine xenobiotic metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
00low000000
2-aminothiazole1,3-thiazoles;
primary amino compound
00low000000
amlodipinedihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound
antihypertensive agent;
calcium channel blocker;
vasodilator agent
00low000000
baclofenamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound
central nervous system depressant;
GABA agonist;
muscle relaxant
00low000000
benserazidecarbohydrazide;
catechols;
primary alcohol;
primary amino compound
antiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
00low000000
butambenamino acid ester;
benzoate ester;
primary amino compound;
substituted aniline
local anaesthetic00low000000
cgs 15943aromatic amine;
biaryl;
furans;
organochlorine compound;
primary amino compound;
quinazolines;
triazoloquinazoline
adenosine A1 receptor antagonist;
adenosine A2A receptor antagonist;
antineoplastic agent;
central nervous system stimulant
00low000000
cystamineorganic disulfide;
primary amino compound
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor00low000000
fipronil(trifluoromethyl)benzenes;
dichlorobenzene;
nitrile;
primary amino compound;
pyrazoles;
sulfoxide
00low000000
tele-methylhistamineimidazoles;
primary amino compound
human metabolite;
mouse metabolite
00low000000
mescalinemethoxybenzenes;
phenethylamine alkaloid;
primary amino compound
hallucinogen00low000000
mexiletinearomatic ether;
primary amino compound
anti-arrhythmia drug00low000000
monodansylcadaverineaminonaphthalene;
primary amino compound;
sulfonamide;
tertiary amino compound
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor;
fluorochrome;
protective agent
00low000000
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
muscimolalkaloid;
isoxazoles;
primary amino compound
fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug
00low000000
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamidenaphthalenes;
organochlorine compound;
primary amino compound;
sulfonamide
00low000000
oxidopaminebenzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
00low000000
o-methyltyramineprimary amino compound00low000000
2-aminopropanolamino alcohol;
primary alcohol;
primary amino compound
00low000000
sulfaphenazoleprimary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
00low000000
terazosinfurans;
piperazines;
primary amino compound;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
00low000000
tosufloxacin1,8-naphthyridine derivative;
amino acid;
aminopyrrolidine;
monocarboxylic acid;
organofluorine compound;
primary amino compound;
quinolone antibiotic;
tertiary amino compound
00low000000
tyraminemonoamine molecular messenger;
primary amino compound;
tyramines
EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
00low000000
tromethamineprimary amino compound;
triol
buffer00low000000
2-anisidinemonomethoxybenzene;
primary amino compound;
substituted aniline
genotoxin;
reagent
00low000000
aminacrineaminoacridines;
primary amino compound
acid-base indicator;
antiinfective agent;
antiseptic drug;
fluorescent dye;
MALDI matrix material;
mutagen
00low000000
4-anisidinemethoxybenzenes;
primary amino compound;
substituted aniline
genotoxin;
reagent
00low000000
betazoleprimary amino compound;
pyrazoles
diagnostic agent;
gastrointestinal drug;
histamine agonist
00low000000
phenetidinearomatic ether;
primary amino compound;
substituted aniline
drug metabolite00low000000
6-aminonicotinamideaminopyridine;
monocarboxylic acid amide;
primary amino compound
antimetabolite;
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor;
teratogenic agent
00low000000
kynuraminekynurenamines;
primary amino compound
metabolite00low000000
neutral red basearomatic amine;
phenazines;
primary amino compound;
tertiary amino compound
acid-base indicator;
dye;
two-colour indicator
00low000000
3-tyramineprimary amino compound;
tyramines
human urinary metabolite;
neurotransmitter
00low000000
2,6-diaminotoluenediamine;
primary amino compound
mutagen00low000000
pyrazonbenzenes;
organochlorine compound;
primary amino compound;
pyridazinone
environmental contaminant;
herbicide;
xenobiotic
00low000000
2-aminothiazoline1,3-thiazoles;
primary amino compound
00low000000
3-phenylpropylaminebenzenes;
phenylalkylamine;
primary amino compound
00low000000
4-aminobutyric acid methyl esteramino acid ester;
methyl ester;
primary amino compound
00low000000
asulamcarbamate ester;
primary amino compound;
substituted aniline;
sulfonamide
agrochemical;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
00low000000
galactosamineD-galactosamine;
primary amino compound
toxin00low000000
didesethylflurazepam1,4-benzodiazepinone;
monofluorobenzenes;
organochlorine compound;
primary amino compound
anticonvulsant;
anxiolytic drug;
drug metabolite;
GABAA receptor agonist;
sedative
00low000000
mecysteineL-cysteinyl ester;
primary amino compound;
thiol
mucolytic00low000000
2,6-diaminopurine2,6-diaminopurines;
primary amino compound
antineoplastic agent00low000000
st 1059aromatic ether;
primary amino compound;
secondary alcohol
alpha-adrenergic agonist;
sympathomimetic agent;
vasoconstrictor agent
00low000000
3-morpholinopropylaminemorpholines;
primary amino compound
00low000000
oseltamiviracetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound
antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic
00low000000
4-methoxybenzylaminearalkylamino compound;
aromatic ether;
primary amino compound
00low000000
5-aminofluoresceinprimary amino compound00low000000
3-methylthiopropylamineorganic sulfide;
primary amino compound
00low000000
4-phenylbutylaminebenzenes;
phenylalkylamine;
primary amino compound
00low000000
caldopentaminepolyazaalkane;
primary amino compound;
secondary amino compound
marine metabolite00low000000
2-amino-5-chlorophenolmonochlorobenzenes;
phenols;
primary amino compound
00low000000
aclonifenaromatic ether;
C-nitro compound;
monochlorobenzenes;
primary amino compound;
substituted aniline
agrochemical;
carotenoid biosynthesis inhibitor;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
gamma-glutamyltyrosinedicarboxylic acid;
dipeptide;
phenols;
primary amino compound;
secondary carboxamide
human metabolite00low000000
3-aminopropylphosphonic acidphosphonic acids;
primary amino compound;
zwitterion
GABAB receptor agonist00low000000
1-amino-1-phenylmethyl phosphonic acidbenzenes;
phosphonic acids;
primary amino compound
00low000000
fingolimodaminodiol;
primary amino compound
antineoplastic agent;
CB1 receptor antagonist;
immunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
00low000000
tafenoquine(trifluoromethyl)benzenes;
aminoquinoline;
aromatic ether;
primary amino compound;
secondary amino compound
00low000000
dopamine 3-o-sulfatearyl sulfate;
phenols;
primary amino compound;
zwitterion
human blood serum metabolite;
human urinary metabolite
00low000000
dopamine 4-o-sulfatearyl sulfate;
phenols;
primary amino compound;
zwitterion
human blood serum metabolite;
human urinary metabolite
00low000000
chrysobactincatechols;
dipeptide;
monocarboxylic acid;
primary alcohol;
primary amino compound
bacterial metabolite;
siderophore
00low000000
cki 7isoquinolines;
organochlorine compound;
primary amino compound;
sulfonamide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor00low000000
7-aminocholesterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
cholestanoid;
primary amino compound
antibacterial agent00low000000
tyramine o-sulfatearyl sulfate;
primary amino compound;
zwitterion
human urinary metabolite;
human xenobiotic metabolite
00low000000
thiobenzyl benzyloxycarbonyl-l-lysinatebenzyl ester;
carbamate ester;
L-lysine derivative;
primary amino compound;
thiocarboxylic ester
00low000000
tipifarnibimidazoles;
monochlorobenzenes;
primary amino compound;
quinolone
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
00low000000
o 129primary amino compound;
pteridines
antifolate;
vibriostatic agent
00low000000
dopamine quinone1,2-benzoquinones;
primary amino compound
metabolite00low000000
n(beta)-alanyldopaminecatechols;
primary amino compound;
secondary carboxamide
00low000000
5-hydroxykynuraminehydroxykynurenamine;
primary amino compound
mouse metabolite00low000000
s-adenosyl-3-thiopropylamineorganic sulfide;
primary amino compound;
thioadenosine
00low000000
aspartimidedicarboximide;
primary amino compound;
pyrrolidinone
Maillard reaction product00low000000
monoacetylcadaverineacetamides;
N-substituted cadaverine;
primary amino compound;
secondary carboxamide
human metabolite00low000000
8-amino-8-demethylriboflavinaromatic amine;
benzopteridine;
primary amino compound;
tetrol
00low000000
nsc 23766aminopyrimidine;
aminoquinoline;
primary amino compound;
secondary amino compound;
tertiary amino compound
antiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
00low000000
paromamineaminoglycoside;
primary amino compound;
triamine
00low000000
phenylalaninolamino alcohol;
amphetamines;
primary alcohol;
primary amino compound
00low000000
n(1)-guanyl-1,7-diaminoheptaneguanidines;
primary amino compound
antineoplastic agent;
EC 2.5.1.46 (deoxyhypusine synthase) inhibitor
00low000000
gs 4071acetate ester;
amino acid;
cyclohexenecarboxylic acid;
primary amino compound
antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
marine xenobiotic metabolite
00low000000
iFSP1aromatic amine;
nitrile;
primary amino compound;
pyridobenzimidazole;
toluenes
antineoplastic agent;
ferroptosis inducer;
ferroptosis suppressor protein 1 inhibitor
00low000000
huperzine aorganic heterotricyclic compound;
primary amino compound;
pyridone;
sesquiterpene alkaloid
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
neuroprotective agent;
nootropic agent;
plant metabolite
00low000000
alpha-acetyllysine methyl esteracetamides;
alpha-amino acid ester;
L-lysine derivative;
methyl ester;
primary amino compound
00low000000
fumonisin b1diester;
fumonisin;
primary amino compound;
triol
carcinogenic agent;
metabolite
00low000000
fumonisin b2diester;
diol;
fumonisin;
primary amino compound
Aspergillus metabolite;
carcinogenic agent
00low000000
dezocinephenols;
primary amino compound
opioid analgesic00low000000
amrubicinanthracycline antibiotic;
methyl ketone;
primary amino compound;
quinone;
tetracenes
antineoplastic agent;
prodrug;
topoisomerase II inhibitor
00low000000
2-nitro-4-phenylenediamineC-nitro compound;
primary amino compound
00low000000
ro 60-0175indoles;
organochlorine compound;
organofluorine compound;
primary amino compound
00low000000
pibutidinearomatic ether;
cyclobutenones;
olefinic compound;
piperidines;
primary amino compound;
pyridines;
secondary amino compound
anti-ulcer drug;
H2-receptor antagonist
00low000000
fortimicin aamino cyclitol glycoside;
aminoglycoside antibiotic;
diol;
monocarboxylic acid amide;
primary amino compound
antibacterial agent;
metabolite
00low000000
a 77636adamantanes;
catechols;
isochromenes;
primary amino compound
antiparkinson drug;
dopamine agonist
00low000000
b 43aromatic amine;
aromatic ether;
cyclopentanes;
primary amino compound;
pyrrolopyrimidine
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
00low000000
nepicastat1,3-dihydroimidazole-2-thiones;
organofluorine compound;
primary amino compound;
tetralins
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor00low000000
l 779976benzimidazoles;
indoles;
piperidinecarboxamide;
primary amino compound;
secondary carboxamide
neuroprotective agent;
somatostatin receptor agonist
00low000000
fty 720pmonoalkyl phosphate;
primary alcohol;
primary amino compound
antineoplastic agent;
immunosuppressive agent;
sphingosine-1-phosphate receptor agonist
00low000000
pateamine a1,3-thiazoles;
macrodiolide;
olefinic compound;
primary amino compound;
tertiary amino compound
antineoplastic agent;
antiviral agent;
eukaryotic initiation factor 4F inhibitor;
marine metabolite
00low000000
er-086526cyclic ketal;
cyclic ketone;
macrocycle;
polycyclic ether;
polyether;
primary amino compound
antineoplastic agent;
microtubule-destabilising agent
00low000000
alogliptinnitrile;
piperidines;
primary amino compound;
pyrimidines
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
00low000000
5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine1,3-thiazoles;
C-nitro compound;
organic sulfide;
primary amino compound;
thiadiazoles
antibacterial agent;
c-Jun N-terminal kinase inhibitor
00low000000
gsk6906931,2,5-oxadiazole;
acetylenic compound;
aromatic amine;
aromatic ether;
imidazopyridine;
piperidines;
primary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
cathestatin bdicarboxylic acid monoamide;
epoxide;
monocarboxylic acid;
phenols;
primary amino compound
antimicrobial agent;
cysteine protease inhibitor;
Penicillium metabolite
00low000000
SL-327(trifluoromethyl)benzenes;
enamine;
nitrile;
organic sulfide;
primary amino compound;
substituted aniline
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor;
neuroprotective agent
00low000000
lucitanibaromatic ether;
cyclopropanes;
naphthalenecarboxamide;
primary amino compound;
quinolines
antineoplastic agent;
fibroblast growth factor receptor antagonist;
vascular endothelial growth factor receptor antagonist
00low000000
fumonisin b4diester;
fumonisin;
primary amino compound;
secondary alcohol
Aspergillus metabolite00low000000
ML240aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent00low000000
torin 2aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
00low000000
crambescidin 800alkaloid;
carboxylic ester;
guanidines;
monocarboxylic acid amide;
organic heteropentacyclic compound;
primary amino compound;
secondary alcohol;
spiro compound
anti-HIV-1 agent;
anti-HSV-1 agent;
antimalarial;
marine metabolite
00low000000
as 1842856organofluorine compound;
primary amino compound;
quinolinemonocarboxylic acid;
quinolone;
secondary amino compound;
tertiary amino compound
anti-obesity agent;
antineoplastic agent;
apoptosis inducer;
autophagy inhibitor;
forkhead box protein O1 inhibitor;
hypoglycemic agent
00low000000
pp242aromatic amine;
biaryl;
hydroxyindoles;
phenols;
primary amino compound;
pyrazolopyrimidine
antineoplastic agent;
mTOR inhibitor
00low000000
dinitrochlorobenzeneC-nitro compound;
monochlorobenzenes
allergen;
epitope;
sensitiser
00low000000
levoplastC-nitro compound00low000000
4-nitrobenzaldehydebenzaldehydes;
C-nitro compound
00low000000
parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
mouse metabolite
00low000000
3-nitropropionic acidC-nitro compoundantimycobacterial drug;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
mycotoxin;
neurotoxin
00low000000
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
azathioprinearyl sulfide;
C-nitro compound;
imidazoles;
thiopurine
antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
00low000000
bay-k-8644(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
00low000000
benefinC-nitro compound;
organofluorine compound;
substituted aniline;
tertiary amino compound
agrochemical;
herbicide
00low000000
dimetridazoleC-nitro compound;
imidazoles
antiparasitic agent;
antiprotozoal drug
00low000000
etanidazoleC-nitro compound;
imidazoles;
monocarboxylic acid amide
alkylating agent;
antineoplastic agent;
prodrug;
radiosensitizing agent
00low000000
flunitrazepam1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes
anxiolytic drug;
GABAA receptor agonist;
sedative
00low000000
methyl parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
00low000000
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
00low000000
nicardipinebenzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
00low000000
niclosamidebenzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
00low000000
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
00low000000
nilutamide(trifluoromethyl)benzenes;
C-nitro compound;
imidazolidinone
androgen antagonist;
antineoplastic agent
00low000000
nimesulidearomatic ether;
C-nitro compound;
sulfonamide
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
00low000000
nimetazepam1,4-benzodiazepinone;
C-nitro compound
anticonvulsant;
antispasmodic drug;
GABA modulator;
sedative
00low000000
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
00low000000
nisoldipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
00low000000
nitrazepam1,4-benzodiazepinone;
C-nitro compound
anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
00low000000
nitrendipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester
antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
00low000000
nizatidine1,3-thiazoles;
C-nitro compound;
carboxamidine;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
cholinergic drug;
H2-receptor antagonist
00low000000
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamidearomatic ether;
C-nitro compound;
sulfonamide
antineoplastic agent;
cyclooxygenase 2 inhibitor
00low000000
oxamniquinearomatic primary alcohol;
C-nitro compound;
quinolines;
secondary amino compound
00low000000
4-nitrophenylacetic acidC-nitro compound;
phenylacetic acids
00low000000
ronidazoleC-nitro compound;
carbamate ester;
imidazoles
antiparasitic agent;
antiprotozoal drug
00low000000
trifluralin(trifluoromethyl)benzenes;
C-nitro compound;
substituted aniline
agrochemical;
environmental contaminant;
herbicide;
xenobiotic
00low000000
4-nitroquinoline-1-oxideC-nitro compound;
quinoline N-oxide
carcinogenic agent00low000000
chloramphenicolC-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
00low000000
niridazole1,3-thiazoles;
C-nitro compound
00low000000
dinitrofluorobenzeneC-nitro compound;
organofluorine compound
agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
00low000000
nifenalolC-nitro compound00low000000
chloropicrinC-nitro compound;
one-carbon compound;
organochlorine compound
antifungal agrochemical;
fumigant insecticide;
nematicide
00low000000
quintozenearomatic fungicide;
C-nitro compound;
pentachlorobenzenes
antifungal agrochemical00low000000
musk ambrette (artificial)C-nitro compound00low000000
1-chloro-2-nitrobenzeneC-nitro compound;
monochlorobenzenes
00low000000
picryl chlorideC-nitro compound;
monochlorobenzenes
allergen;
epitope;
explosive;
hapten
00low000000
picric acidC-nitro compoundantiseptic drug;
explosive;
fixative
00low000000
2,4-dinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
00low000000
2-nitro-4-methylanilineC-nitro compound00low000000
3,5-dinitrobenzoic acidbenzoic acids;
C-nitro compound
00low000000
5-nitro-2-toluidineC-nitro compound00low000000
4-chloronitrobenzeneC-nitro compound00low000000
4-nitrobenzyl chloridebenzyl chlorides;
C-nitro compound
mutagen00low000000
4-nitroacetophenoneacetophenones;
C-nitro compound
00low000000
tecnazenearomatic fungicide;
C-nitro compound;
tetrachlorobenzene
antifungal agrochemical00low000000
4-amino-2-nitrotolueneC-nitro compound00low000000
2-amino-5-nitrothiazoleC-nitro compound;
thiazoles
00low000000
naphthol yellowC-nitro compound;
naphthalenesulfonic acid;
naphthols
histological dye00low000000
azomycinC-nitro compound;
imidazoles
antitubercular agent00low000000
trinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
epitope;
explosive;
reagent
00low000000
2-nitrobenzaldehydebenzaldehydes;
C-nitro compound
00low000000
1-bromo-2,4-dinitrobenzeneC-nitro compound;
organobromine compound
00low000000
3,5-dinitrosalicylic acidC-nitro compound;
monohydroxybenzoic acid
hapten00low000000
3,5-dinitrotolueneC-nitro compound00low000000
2-methyl-5-nitroimidazoleC-nitro compound;
imidazoles
00low000000
5-nitro-2-furaldehydeC-nitro compound;
furans
00low000000
4-nitrophenyl acetateC-nitro compound;
phenyl acetates
00low000000
methylparaoxonC-nitro compound00low000000
dinobutonC-nitro compound00low000000
pyrrolnitrinalkaloid;
C-nitro compound;
monochlorobenzenes;
pyrroles
antifungal drug;
bacterial metabolite
00low000000
dinoterbC-nitro compound;
phenols
00low000000
2,4-dinitrothiocyanatobenzeneC-nitro compound;
thiocyanates
hapten;
tolerogen
00low000000
2,4,6-trichlorophenyl 4-nitrophenyl etheraromatic ether;
C-nitro compound;
chlorobenzenes
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzeneC-nitro compound00low000000
4-nitroimidazoleC-nitro compound;
imidazoles
00low000000
2-(alpha-thenoylamino)-2-nitro-5-thiazole1,3-thiazoles;
C-nitro compound
00low000000
nitroxolineC-nitro compound;
monohydroxyquinoline
antifungal agent;
antiinfective agent;
antimicrobial agent;
renal agent
00low000000
nitralinC-nitro compound00low000000
1,2-epoxy-3-(p-nitrophenoxy)propanearomatic ether;
C-nitro compound;
epoxide
00low000000
nimorazoleC-nitro compound;
imidazoles
00low000000
4-chloro-7-nitrobenzofurazanbenzoxadiazole;
C-nitro compound;
organochlorine compound
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor;
fluorescent probe;
fluorochrome
00low000000
ipronidazoleC-nitro compound;
imidazoles
00low000000
ornidazoleC-nitro compound;
imidazoles;
organochlorine compound;
secondary alcohol
antiamoebic agent;
antibacterial drug;
antiinfective agent;
antiprotozoal drug;
antitrichomonal drug;
epitope
00low000000
oryzalinaromatic amine;
C-nitro compound;
sulfonamide;
tertiary amino compound
agrochemical;
antimitotic;
herbicide
00low000000
fenitrothionC-nitro compound;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
00low000000
benzonidazoleC-nitro compound;
imidazoles;
monocarboxylic acid amide
antiprotozoal drug00low000000
N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimineC-nitro compound;
furans
00low000000
3-nitro-1-propanolC-nitro compound00low000000
amoscanateC-nitro compound;
isothiocyanate;
secondary amino compound
schistosomicide drug00low000000
profluralinC-nitro compound00low000000
dinitramineC-nitro compound00low000000
hc blue no. 2C-nitro compound00low000000
fluchloralinC-nitro compound00low000000
butralinC-nitro compound00low000000
isopropalinC-nitro compound00low000000
pendimethalinC-nitro compound;
secondary amino compound;
substituted aniline
agrochemical;
environmental contaminant;
herbicide
00low000000
ethafluralinC-nitro compound00low000000
acifluorfenaromatic ether;
benzoic acids;
C-nitro compound;
monocarboxylic acid;
organochlorine compound;
organofluorine compound
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
bromethalinC-nitro compound00low000000
fomesafenaromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
bmy 25067C-nitro compound;
organic disulfide
antineoplastic agent00low000000
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazoleC-nitro compound;
furans
00low000000
musk xyleneC-nitro compoundcarcinogenic agent;
explosive;
fragrance
00low000000
4-nitrophenylalanineC-nitro compound00low000000
4-nitrobenzyl bromidebenzyl bromides;
C-nitro compound
allergen;
sensitiser
00low000000
nitarsoneC-nitro compound;
organoarsonic acid
agrochemical;
antiprotozoal drug
00low000000
5'-nitro-2'-propoxyacetanilidearomatic ether;
C-nitro compound
00low000000
cinitapridearomatic ether;
C-nitro compound
00low000000
5-nitrouracilC-nitro compound00low000000
3-nitrobenzyl alcoholC-nitro compound00low000000
4-nitrobenzyl alcoholbenzyl alcohols;
C-nitro compound
xenobiotic metabolite00low000000
secnidazoleC-nitro compound;
imidazoles;
secondary alcohol
epitope00low000000
4-nitrophenyl palmitateC-nitro compound;
hexadecanoate ester
00low000000
4-nitrophenyl butyratebutyrate ester;
C-nitro compound
00low000000
2-nitrophenylacetic acidC-nitro compound;
phenylacetic acids
00low000000
4-nitrophenyl sulfatearyl sulfate;
C-nitro compound
human metabolite00low000000
4-nitrophenyl-alpha-l-fucosidealpha-L-fucoside;
C-nitro compound
chromogenic compound00low000000
4-nitrophenylglucuronidebeta-D-glucosiduronic acid;
C-nitro compound
chromogenic compound00low000000
chloramphenicol stearateC-nitro compound00low000000
4,5-dimethoxy-2-nitrobenzaldehydearomatic ether;
C-nitro compound
00low000000
4-nitrophenyl beta-d-xylosideC-nitro compound;
xyloside
chromogenic compound00low000000
fluazinam(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound
allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
00low000000
2-nitropropanolC-nitro compound00low000000
4-nitrophenyl beta-d-glucosidebeta-D-glucoside;
C-nitro compound
chromogenic compound00low000000
4-nitrophenyl alpha-glucosidealpha-D-glucoside;
C-nitro compound;
monosaccharide derivative
chromogenic compound00low000000
bnps-skatolearyl sulfide;
bromoindole;
C-nitro compound
reagent00low000000
nitrophenylgalactosidesbeta-D-galactoside;
C-nitro compound
chromogenic compound00low000000
6-n-(2,4-dinitrophenyl)aminohexanoic acidC-nitro compound00low000000
5-nitro-2-(1-piperidinyl)pyridineC-nitro compound00low000000
s-(4-nitrobenzyl)glutathioneC-nitro compound;
organic sulfide;
S-substituted glutathione
00low000000
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranosideC-nitro compound;
N-acetyl-beta-D-glucosaminide
chromogenic compound00low000000
miserotoxinbeta-D-glucoside;
C-nitro compound
phytotoxin00low000000
aristolochic acid iiaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
nitisinone(trifluoromethyl)benzenes;
C-nitro compound;
cyclohexanones;
mesotrione
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor00low000000
efonidipineC-nitro compound;
carboxylic ester;
dihydropyridine;
tertiary amino compound
00low000000
1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazoleC-nitro compound;
imidazoles
00low000000
pyrrolomycin aantibiotic antifungal agent;
C-nitro compound;
organochlorine compound;
pyrroles
antibacterial agent;
bacterial metabolite
00low000000
2,8-dinitroimipramineC-nitro compound;
dibenzoazepine;
tertiary amino compound
00low000000
7-nitrobenzoxadiazole-6-aminohexanoic acidbenzoxadiazole;
C-nitro compound;
epsilon-amino acid;
secondary amino compound
fluorochrome00low000000
aristolochic acid Daristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
nephrotoxin;
toxin
00low000000
ag 3-5C-nitro compound00low000000
thymidine 5'-4-nitrophenyl phosphatearyl phosphate;
C-nitro compound;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
00low000000
aristolochic acid caristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
mesotrionearomatic ketone;
beta-triketone;
C-nitro compound;
sulfone
carotenoid biosynthesis inhibitor;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
00low000000
3-nitrotyrosine2-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
00low000000
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrilearomatic ether;
C-nitro compound
00low000000
N-(4-nitrophenyl)-2-phenoxyacetamideC-nitro compound00low000000
rubitecanC-nitro compound;
delta-lactone;
pyranoindolizinoquinoline;
semisynthetic derivative;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
00low000000
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazoleC-nitro compound00low000000
7-nitro-5-indeno[1,2-b]pyridinoneC-nitro compound00low000000
5-(4-nitrophenyl)-4-phenyl-2-thiazolamineC-nitro compound00low000000
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamideC-nitro compound00low000000
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenolaromatic ether;
C-nitro compound
00low000000
N-(6-methyl-2-pyridinyl)-5-nitro-2-furancarboxamideC-nitro compound;
furans
00low000000
(3,5-dimethyl-1-pyrazolyl)-(2-ethyl-4-nitro-3-pyrazolyl)methanoneC-nitro compound00low000000
N-(4-methyl-2-pyridinyl)-5-nitro-2-furancarboxamideC-nitro compound;
furans
00low000000
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-oneC-nitro compound00low000000
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamidearomatic ether;
C-nitro compound
00low000000
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamideC-nitro compound00low000000
N-(2-fluoro-5-nitrophenyl)-2,2-dimethylbutanamideC-nitro compound00low000000
3-(2-methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-oneC-nitro compound00low000000
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazineC-nitro compound00low000000
5-hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-oneC-nitro compound00low000000
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)ureaaromatic ether;
C-nitro compound
00low000000
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamidearomatic ether;
C-nitro compound
00low000000
2-[[cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl esterC-nitro compound00low000000
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)ureaaromatic ether;
C-nitro compound
00low000000
N-(5-tert-butyl-3-isoxazolyl)-3-nitrobenzamideC-nitro compound00low000000
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamideC-nitro compound00low000000
N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amineC-nitro compound00low000000
4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamideC-nitro compound00low000000
4-methyl-2-(4-nitrophenyl)-5-thiazolecarboxylic acidC-nitro compound00low000000
5-carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl esterC-nitro compound00low000000
4-(3,5-dimethyl-4-nitro-1-pyrazolyl)butanoic acidC-nitro compound00low000000
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl esteraromatic ether;
C-nitro compound
00low000000
N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]-4-methylbenzamideC-nitro compound00low000000
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trionearomatic ether;
C-nitro compound
00low000000
stattic1-benzothiophenes;
C-nitro compound;
sulfone
antineoplastic agent;
radiosensitizing agent;
STAT3 inhibitor
00low000000
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamidearomatic ether;
C-nitro compound
00low000000
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrilearomatic ether;
C-nitro compound
00low000000
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamidearomatic ether;
C-nitro compound
00low000000
N2-tert-butyl-6-ethoxy-N4-(4-nitrophenyl)-1,3,5-triazine-2,4-diamineC-nitro compound00low000000
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamideC-nitro compound00low000000
2-methyl-N-[5-(4-nitrophenyl)sulfonyl-2-thiazolyl]pentanamideC-nitro compound00low000000
N-[(2-ethyl-1-piperidinyl)-sulfanylidenemethyl]-4-nitrobenzamideC-nitro compound00low000000
4-[[3-methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-oneC-nitro compound00low000000
N-(4-chloro-3-nitrophenyl)-3-phenylbutanamideC-nitro compound00low000000
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzeneC-nitro compound;
sulfonamide;
toluenes
bone density conservation agent;
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor;
geroprotector
00low000000
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamidearomatic ether;
C-nitro compound
00low000000
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)ureaaromatic ether;
C-nitro compound
00low000000
5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamideC-nitro compound00low000000
ranitidineC-nitro compound;
furans;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
00low000000
carnidazoleC-nitro compound;
imidazoles
00low000000
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamidearomatic ether;
C-nitro compound
00low000000
N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamideC-nitro compound;
furans
00low000000
3-nitro-N'-(2,4,6-trichlorophenyl)benzohydrazideC-nitro compound00low000000
2-(2,2-dimethyl-4-oxanyl)-4-(4-nitrophenyl)thiazoleC-nitro compound00low000000
5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amineC-nitro compound00low000000
3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamideC-nitro compound00low000000
N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamideC-nitro compound00low000000
N-(4-fluorophenyl)-5-nitro-2-pyridinamineC-nitro compound00low000000
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamideC-nitro compound;
thiazoles
00low000000
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamideC-nitro compound00low000000
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] esterC-nitro compound;
thiophenes
00low000000
2-[(5-amino-1H-1,2,4-triazol-3-yl)thio]-N-(2-bromo-4-nitrophenyl)acetamideC-nitro compound00low000000
4-nitrophenylhydrazineC-nitro compound;
phenylhydrazines
mutagen00low000000
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amineC-nitro compound00low000000
2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrileC-nitro compound;
furans
00low000000
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamineC-nitro compound00low000000
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamineC-nitro compound00low000000
4-nitrocatecholC-nitro compound;
catechols
human xenobiotic metabolite;
lipoxygenase inhibitor
00low000000
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]ureaaromatic ether;
C-nitro compound
00low000000
nefurthiazoleC-nitro compound;
furans
00low000000
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamideC-nitro compound;
thiophenes
00low000000
2-[(4-aminophenyl)thio]-N-(3-nitrophenyl)acetamideC-nitro compound00low000000
3-[4-(2-hydroxyethylamino)-3-nitrophenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-oneC-nitro compound00low000000
2-[[6-amino-2-(3-methylanilino)-5-nitro-4-pyrimidinyl]amino]ethanolC-nitro compound00low000000
N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamineC-nitro compound00low000000
3-nitro-N-(2-phenylethyl)-2-pyridinamineC-nitro compound00low000000
2-(4-nitrophenyl)-4-thiazolecarboxylic acid ethyl esterC-nitro compound00low000000
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amineC-nitro compound00low000000
2,4-dinitrophenylhydrazineC-nitro compound;
phenylhydrazines
reagent00low000000
3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamideC-nitro compound00low000000
5-methyl-2-[[(4-nitrophenyl)-oxomethyl]hydrazo]-4-thiazolecarboxylic acid ethyl esterC-nitro compound00low000000
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamidearomatic ether;
C-nitro compound
00low000000
5-nitro-2-thiophenecarboxylic acid [1-[(3,5-dichloro-2-pyridinyl)amino]-1-oxopropan-2-yl] esterC-nitro compound;
thiophenes
00low000000
N-[2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl]-4-nitroanilineC-nitro compound00low000000
4-nitrocaramiphenC-nitro compound00low000000
4-[(3-methyl-5-nitro-4-imidazolyl)amino]phenolC-nitro compound;
imidazoles
00low000000
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamidearomatic ether;
C-nitro compound
00low000000
N2-(3-methylphenyl)-6-(4-morpholinyl)-5-nitropyrimidine-2,4-diamineC-nitro compound00low000000
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamideC-nitro compound;
secondary carboxamide;
tertiary carboxamide;
trifluoroacetamide
00low000000
2-[[6-amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanolC-nitro compound00low000000
4-(3-chlorophenyl)sulfonyl-N-cyclohexyl-N-methyl-3-nitrobenzamideC-nitro compound00low000000
6-(2-methyl-1-piperidinyl)-5-nitro-4-pyrimidinamineC-nitro compound00low000000
1-(5-nitro-2-thiophenyl)piperidineC-nitro compound;
thiophenes
00low000000
N-[2-(2,4,6-trinitrophenyl)ethyl]anilineC-nitro compound00low000000
N2-(2-furanylmethyl)-5-nitro-6-(1-pyrrolidinyl)pyrimidine-2,4-diamineC-nitro compound00low000000
1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanoneC-nitro compound00low000000
N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamideC-nitro compound00low000000
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] esterC-nitro compound;
thiophenes
00low000000
2-(2,3-dihydroxypropylamino)-5-nitro-3-pyridinecarbonitrileC-nitro compound00low000000
2-[(2-nitrophenyl)thio]-1-cyclooctanoneC-nitro compound00low000000
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] esterC-nitro compound;
thiophenes
00low000000
N2-(2-furanylmethyl)-6-(3-methyl-1-piperidinyl)-5-nitropyrimidine-2,4-diamineC-nitro compound00low000000
N'-(4-nitrophenyl)-9-oxo-3-bicyclo[3.3.1]nonanecarbohydrazideC-nitro compound00low000000
alsterpaulloneC-nitro compound;
caprolactams;
organic heterotetracyclic compound
anti-HIV-1 agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor
00low000000
2-(4-fluoro-3-nitrophenyl)-4,4-dimethyl-5H-oxazoleC-nitro compound00low000000
N'-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]-4-nitrobenzohydrazideC-nitro compound00low000000
furylfuramideacrylamides;
C-nitro compound;
nitrofuran antibiotic;
primary carboxamide
00low000000
cilnidipine2-methoxyethyl ester;
C-nitro compound;
dihydropyridine
antihypertensive agent;
calcium channel blocker;
cardiovascular drug
00low000000
ro 61-8048C-nitro compound00low000000
meptyldinocapC-nitro compound;
enoate ester
00low000000
l796778benzenes;
C-nitro compound;
L-lysine derivative;
L-phenylalanine derivative;
methyl ester;
oligopeptide;
secondary carboxamide;
ureas
somatostatin receptor agonist00low000000
amocarzineC-nitro compound;
N-methylpiperazine;
secondary amino compound;
thioureas
antinematodal drug00low000000
nitrovinC-nitro compound;
furans
00low000000
dihydroxymethylfuratrizineC-nitro compound;
furans
00low000000
nifurpirinolC-nitro compound;
furans
00low000000
azanidazoleC-nitro compound;
imidazoles
00low000000
aureothin4-pyranones;
C-nitro compound;
ketene acetal;
olefinic compound;
oxolanes
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
00low000000
nidroxyzoneC-nitro compound;
furans
00low000000
nifurzideC-nitro compound;
thiophenes
00low000000
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
[4-(2-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanoneC-nitro compound00low000000
2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamideC-nitro compound00low000000
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphateC-nitro compound;
spiroketal
antagonist00low000000
2-(4-morpholinyl)-N'-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazideC-nitro compound00low000000
N'-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazideC-nitro compound00low000000
ML-210C-nitro compound;
diarylmethane;
isoxazoles;
monochlorobenzenes;
N-acylpiperazine;
N-alkylpiperazine;
tertiary carboxamide
antineoplastic agent;
EC 1.11.1.9 (glutathione peroxidase) inhibitor;
ferroptosis inducer;
prodrug
00low000000
abt-199aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
chir 98014aminopyrimidine;
C-nitro compound;
diaminopyridine;
dichlorobenzene;
imidazoles;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
hypoglycemic agent;
tau aggregation inhibitor;
Wnt signalling activator
00low000000
acenocoumarolC-nitro compound;
hydroxycoumarin;
methyl ketone
anticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
00low000000
8-nitroguanosine 3',5'-cyclic monophosphate3',5'-cyclic purine nucleotide;
C-nitro compound
biomarker;
Brassica napus metabolite;
human metabolite;
signalling molecule
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
dinitrochlorobenzeneC-nitro compound;
monochlorobenzenes
allergen;
epitope;
sensitiser
1991199133.0low001000
4-nitrobenzaldehydebenzaldehydes;
C-nitro compound
1991199133.0low001000
2-aminofluorene2013201311.0low000010
7-nitroindazole1991199133.0low001000
carbamazepinedibenzoazepine;
ureas
analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
201620168.0low000010
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
201620168.0low000010
isoniazidcarbohydrazideantitubercular agent;
drug allergen
2013201311.0low000010
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
1991199133.0low001000
mirtazapinebenzazepine;
tetracyclic antidepressant
alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
201920195.0low000010
nefazodonearomatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles
alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
201920195.0low000010
pentamidinearomatic ether;
carboxamidine;
diether
anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
201520159.0low000010
quetiapinedibenzothiazepine;
N-alkylpiperazine;
N-arylpiperazine
adrenergic antagonist;
dopaminergic antagonist;
histamine antagonist;
second generation antipsychotic;
serotonergic antagonist
201920195.0low000010
mitomycinmitomycinalkylating agent;
antineoplastic agent
201520197.0low000020
niridazole1,3-thiazoles;
C-nitro compound
1991199133.0low001000
dinitrofluorobenzeneC-nitro compound;
organofluorine compound
agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
1991199133.0low001000
1-nitronaphthalenemononitronaphthaleneenvironmental contaminant;
mouse metabolite
1991199133.0low001000
1-chloro-2-nitrobenzeneC-nitro compound;
monochlorobenzenes
1991199133.0low001000
2,5-dichloronitrobenzene1991199133.0medium001000
2-nitroanisole2-nitroanisolescarcinogenic agent1991199133.0low001000
4-nitrobiphenylbiphenyls1991199133.0low001000
2,4-dinitroanilinenitroaniline1991199133.0low001000
nitrobenzenenitroarene;
nitrobenzenes
1991199133.0low001000
1,2-dichloro-4-nitrobenzene1991199133.0low001000
3-dinitrobenzenedinitrobenzeneneurotoxin1991199133.0low001000
4-chloronitrobenzeneC-nitro compound1991199133.0low001000
4-nitroanisole4-nitroanisoles1991199133.0low001000
4-nitroacetophenoneacetophenones;
C-nitro compound
1991199133.0low001000
1,4-dinitrobenzenedinitrobenzene1991199133.0low001000
2,4-dinitroanisoledinitroanisolesexplosive1991199133.0low001000
2,4,7-trinitrofluorenone1991199133.0low001000
1,2-dinitrobenzenedinitrobenzene1991199133.0low001000
2-nitrobenzaldehydebenzaldehydes;
C-nitro compound
1991199133.0low001000
nicotinic acid hydrazide2013201311.0low000010
2-nitronaphthalenemononitronaphthalene1991199133.0low001000
9-nitroanthraceneanthracenes1991199133.0low001000
5-nitroacenaphthenenitronaphthalene1991199133.0high001000
erythropoietindinitronaphthalenegenotoxin1991199133.0low001000
1,3-dinitronaphthalenedinitronaphthalene1991199133.0low001000
5-nitroquinoline1991199133.0low001000
2-nitrofluorenenitroarenecarcinogenic agent;
mutagen
1991199133.0low001000
2,4-dichloro-1-nitrobenzene1991199133.0low001000
2-anthramineanthracenamine201520159.0low000010
5-nitro-2-furaldehydeC-nitro compound;
furans
1991199133.0low001000
2-nitropyrenepyrenes1991199133.0low001000
3-nitrofluoranthenenitronaphthalene1991199133.0low001000
2-amino-7-nitrofluorene1991199133.0medium001000
2-bromo-4,6-dinitroaniline1991199133.0low001000
5-nitroindazole1991199133.0low001000
2,7-dinitrofluorene1991199133.0medium001000
1-nitropyrenenitroarenecarcinogenic agent1991199133.0low001000
nsc 5205941991199133.0low001000
2-hydroxy-7-nitrofluorene1991199133.0medium001000
6-nitrochrysenecarbopolycyclic compound1991199133.0low001000
6-nitroindazole1991199133.0low001000
2-nitrofluoranthene1991199133.0low001000
7-nitrobenzanthracenephenanthrenes1991199133.0medium001000
3,9-dinitrofluoranthenenitronaphthalene1991199133.0medium001000
sodium azideinorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
201520197.3low000030
2,7-dinitrofluorenone1991199133.0medium001000
1,6-dinitropyrenepyrenes1991199133.0low001000
1,8-dinitropyrenepyrenes1991199133.0low001000
6-nitrobenzo(a)pyreneortho- and peri-fused polycyclic arene1991199133.0low001000
1-nitrobenzo(a)pyrene1991199133.0low001000
3-nitrobenzo(a)pyrene1991199133.0low001000
1,3-dinitropyrenepyrenes1991199133.0low001000
3,7-dinitrofluoranthenenitronaphthalene1991199133.0medium001000
4-nitropyrenepyrenes1991199133.0low001000
3-nitroperylenephenanthrenes1991199133.0high001000
1-nitro-2,4-difluorobenzene1991199133.0medium001000
5-nitroisoquinoline1991199133.0high001000
9-nitrophenanthrene1991199133.0medium001000
5-nitro-1,10-phenanthroline1991199133.0low001000
1-fluoro-2-nitrobenzene1991199133.0low001000
3,4-methylenedioxybenzoic acid hydrazide2013201311.0medium000010
2-nitrobenzimidazole1991199133.0medium001000
e 64dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
201520159.0low000010
2,4-dinitrophenylhydrazineC-nitro compound;
phenylhydrazines
reagent1991199133.0low001000
2-nitro-4-phenylenediamineC-nitro compound;
primary amino compound
1991199133.0low001000
5-Nitroisatinindolesanticoronaviral agent1991199133.0low001000
2-amino-5-nitrophenol3-nitrophenols1991199133.0low001000
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
2013201510.0low000020
furazolidone1991199133.0low001000
nitrofurazone1991199133.0low001000
nitrofurantoinimidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic
antibacterial drug;
antiinfective agent;
hepatotoxic agent
1991199133.0low001000
nifurtimoxnitrofuran antibiotic2013201311.0low000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
acetoneketone body;
methyl ketone;
propanones;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
2002200222.0low000100
diacetylalpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
2012201212.0low000010
pyruvaldehyde2-oxo aldehyde;
propanals
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997199727.0low001000
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1993201820.2low001210
pyrazolepyrazole202020204.0low000010
2-aminofluorene1986200826.0low022500
3-nitropropionic acidC-nitro compoundantimycobacterial drug;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
mycotoxin;
neurotoxin
1995199529.0low001000
ampyroneprimary amino compound;
pyrazolone
antipyretic;
antirheumatic drug;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
marine xenobiotic metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1993199331.0low001000
benzo(a)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
1990200425.8low003200
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2005200519.0low000100
dimethoatemonocarboxylic acid amide;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
2001200123.0low000100
methyl parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
2001200123.0low000100
methyl methanesulfonatemethanesulfonate esteralkylating agent;
apoptosis inducer;
carcinogenic agent;
genotoxin;
mutagen
2014201410.0low000010
2-acetylaminofluorene2-acetamidofluorenesantimitotic;
carcinogenic agent;
epitope;
mutagen
2002200520.5low000200
9,10-dimethyl-1,2-benzanthraceneortho-fused polycyclic arene;
tetraphenes
carcinogenic agent2002200520.5low000200
ethyl methanesulfonatemethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
genotoxin;
mutagen;
teratogenic agent
1993199331.0low001000
histidineamino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2000200024.0low001000
cumene hydroperoxideperoxolenvironmental contaminant;
Mycoplasma genitalium metabolite;
oxidising agent
1993199331.0low001000
1-nitronaphthalenemononitronaphthaleneenvironmental contaminant;
mouse metabolite
1995199529.0low001000
quinoxalinesmancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
2011201113.0low000010
2-toluidineaminotoluenecarcinogenic agent1989198935.0low010000
4-chloro-1,2-diaminobenzenemonochlorobenzenes1989199134.0low011000
4-phenylenediaminephenylenediamineallergen;
dye;
hapten;
reagent
1991199531.0low002000
3-phenylenediaminephenylenediamine2001200421.5low000200
ethyl acetateacetate ester;
ethyl ester;
volatile organic compound
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
catechincatechinantioxidant;
plant metabolite
1996199628.0low001000
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
202020204.0low000010
azomycinC-nitro compound;
imidazoles
antitubercular agent202020204.0low000010
2-anthramineanthracenamine2014201410.0low000010
1-methyl-5-chloro-4-nitroimidazole202020204.0low000010
mercuryelemental mercury;
zinc group element atom
neurotoxin201920195.0low000010
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
1999199925.0low001000
phenyl acetatebenzenes;
phenyl acetates
1993199331.0low001000
sodium azideinorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
1989201420.4low011820
azidespseudohalide anionmitochondrial respiratory-chain inhibitor1989198935.0low010000
2-amino-3,8-dimethylimidazo(4,5-f)quinoxalinearomatic amine;
imidazoquinoxaline
carcinogenic agent;
genotoxin;
Maillard reaction product;
mutagen
2011201113.0low000010
acridine orangeaminoacridines;
aromatic amine;
tertiary amino compound
fluorochrome;
histological dye
2011201113.0low000010
piaselenole2012201212.0low000010
hydroxyl radicaloxygen hydride;
oxygen radical;
reactive oxygen species
2011201113.0low000010
aflatoxin b1aflatoxin;
aromatic ether;
aromatic ketone
carcinogenic agent;
human metabolite
1999201419.0low001110
2-amino-5-methylthiazole202020204.0medium000010
thioureaone-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
202320231.0low000001
1,1-diphenyl-2-picrylhydrazyl2014201410.0low000010
crocin201920195.0low000010
2-nitro-4-phenylenediamineC-nitro compound;
primary amino compound
1997200025.5low002000
3-nitro-o-phenylenediamine1997200025.5medium002000
ajoenesulfoxide1996199628.0low001000
seleniumchalcogen;
nonmetal atom
micronutrient1976199240.0low011000
oxadiazoles2004200420.0low000100
tannins2000200024.0low001000
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
2004200420.0low000100
methylnitronitrosoguanidinenitroso compoundalkylating agent2002201118.0low000210
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Abnormalities, Autosome01989198935.0low010000
Absence Seizure0201620168.0low000010
Benign Neoplasms, Brain0202320231.0low000001
Brain Neoplasms0202320231.0low000001
Cell Transformation, Neoplastic02004200420.0low000100
Chromosome-Defective Micronuclei01989198935.0low010000
Condition, Preneoplastic02002200222.0low000100
Disease Models, Animal0201620168.0low000010
Leucocythaemia02009200915.0low000100
Leukemia02009200915.0low000100
Neglected Diseases02013201311.0low000010
Precancerous Conditions02002200222.0low000100
Seizures0201620168.0low000010

Safety/Toxicity (1)

ArticleYear
Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols.
European journal of medicinal chemistry, , Jan-01, Volume: 107
2016